MUMBAI, India, May 2, 2025 /PRNewswire/ — CHANEL announces the launch of its Fragrance & Beauty products on Nykaa, India’s leading beauty and lifestyle destination digital-first consumer tech company, serving over 40 million customers through its online platforms and 221+ offline beauty destinations. CHANEL Fragrance & Beauty products will be available through a select offering of Nykaa Luxe stores spread across the country and online via Nykaa’s app and website.

CHANEL’s presence on Nykaa is designed with the unique style of the House that creates a luxurious and delightful space where clients can enjoy shopping while discovering about the brand’s heritage, as well as new, innovative product ranges.

Each order of a CHANEL product placed through Nykaa’s online platforms is packaged in a delicate and environment-friendly wrapping, with a complimentary sample and a thank you card. CHANEL is committed to continuously advancing its luxury offline shopping experience to online shoppers.

For a brick-and-mortar experience, clients can visit Nykaa Luxe’s stores in Palladium Mall, Mumbai, 100 Feet Road in Bengaluru and Nexus Elante Mall, Chandigarh. By the end of 2025, CHANEL will be available in over 10 Nykaa Luxe stores across the country.

Since 2013, CHANEL’s wholly-owned Fragrance & Beauty has been expanding and currently comprises of seven boutiques across the country—four in the National Capital Region, namely in DLF Promenade, Select Citywalk Mall Saket, Mall of India, Noida and Ambience Mall Gurugram; two in Mumbai: housed in Phoenix Palladium and Jio World Drive, and one in Bengaluru’s Mall of Asia.

From a travel retail perspective, CHANEL has a presence in the Indira Gandhi International Airport, New Delhi, the Chhatrapati Shivaji Maharaj International Airport, Mumbai and Rajiv Gandhi International Airport, Hyderabad. CHANEL launched its e-commerce portal (www.chanel.com/in) last year that serve over 27,000 postcodes in India. The e-commerce portal is an extension of the brand, providing an online source through which our clients outside metro cities can access CHANEL fragrance and beauty and eyewear products, while experiencing exceptional luxury service.

“Building upon the foundation laid by our network of fragrance and beauty boutiques and Chanel India’s e-commerce platform, this momentous partnership with Nykaa, a true leader in the Indian beauty landscape, represents a powerful synergy of our shared values – a dedication to curated experiences and a profound understanding of the Indian consumer. The meticulous attention to detail evident in Chanel’s presence on Nykaa underscores our shared commitment to excellence. This collaboration inspires us to envision an even more expansive and impactful future for our fragrance and beauty offerings in India.” – Amit Goyal, Managing Director India, CHANEL.

With CHANEL Fragrance & Beauty Products available on Nykaa, the House once again pushes the limits of luxurious and meaningful shopping experiences. “Chanel has for decades defined and redefined the meaning of luxury and beauty. At Nykaa, we take immense pride in partnering with the Maison to launch CHANEL Fragrance & Beauty in India for the first time in Nykaa’s luxury beauty stores as well as online. Chanel’s early recognition of India’s potential will go a long way in creating and growing the luxury segment for decades to come. We look forward to this new chapter with Chanel and are excited to see Indian consumers embrace the rich history and legacy of Chanel.” – Anchit Nayar, Executive Director and CEO, Nykaa Beauty.

Shop now on Nykaa.com: Link

PRESS ROOM: CHANEL FRAGRANCE AND BEAUTY LAUNCHES ON NYKAA

Photo: https://mma.prnewswire.com/media/2678609/Nykaa_Chanel.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/chanel-fragrance-and-beauty-launches-on-nykaa-302445048.html

HONG KONG, May 2, 2025 /PRNewswire/ — UpTech has announced that they have been awarded the “Best Risk Management Solutions Provider UAE” and “Best Trading Technology Provider UAE” by the International Business Magazine Awards 2025.

The International Business Magazine Awards is designed to highlight the exemplary endeavors of core corporate players who consistently demonstrate exceptional leadership abilities. These accolades underscore UpTech’s unwavering commitment to excellence, innovation, and client success in the UAE’s dynamic financial sector.

Recognition for Innovation and Excellence

UpTech has been acknowledged for its contributions to risk management and trading technology, receiving awards from International Business Magazine after a competitive evaluation process. The recognition underscores the company’s role in delivering scalable technology solutions designed to support business operations in evolving markets.

These accolades reflect the ongoing efforts of UpTech’s team to develop robust platforms and maintain high standards in technological advancement.

‌Why UpTech Stands Out‌

Risk Management Solutions‌: UpTech’s proprietary algorithms and real-time analytics enable institutions to navigate volatility with precision, offering customizable tools that optimize decision-making.

Next-Gen Trading Technology‌: The trading solution provides seamless execution, ultra-low latency, and predictive insights, setting a new benchmark for user experience and performance.

UpTech’s unique ability to merge technological sophistication with user-centric design, delivering powerful and accessible solutions to clients of all sizes. UpTech is dedicated to helping their clients achieve ultra-low latency and superior security levels for their trading environments.

Appreciation and Continued Commitment from UpTech

UpTech extends its appreciation to all clients and partners for their continued trust and collaboration. The company remains committed to supporting its stakeholders through reliable technology solutions and looks forward to strengthening these partnerships as it continues to grow and evolve.

About UpTech

UpTech is a leading financial technology provider specializing in tailor-made service solutions for brokerages and exchange firms. With the team’s 14 years of industry experience, UpTech continues to innovate and drive the financial technology sector forward, earning recognition and accolades that solidify its position as a trusted partner in the ever-evolving financial landscape. 

Users can explore UpTech’s award-winning solutions here

Contact:
Sales Team
UpTech
sales@uptech.info

Photo: https://mma.prnewswire.com/media/2678639/UpTech_Award.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/uptech-wins-best-risk-management-solutions-provider-uae–and-best-trading-technology-provider-uae-awards-2025-302445052.html

SOURCE UpTech

STOCKHOLM, May 2, 2025 /PRNewswire/ — RaySearch Laboratories AB (publ) is proud to announce that The Royal Marsden NHS Foundation Trust in the UK has treated its first patient using a new and groundbreaking workflow, enabled by the new adaptive replanning module, released in the latest version of RayStation®*. The treatment was carried out with Accuray’s treatment machine Radixact®, RayStation, and The Royal Marsden’s existing oncology information system. The first patient was successfully treated in March 2025.

With this treatment, The Royal Marsden has demonstrated the effectiveness and efficiency of the new module in RayStation and while this is a significant step forward in terms of time savings, both for patients and for the hospital, there remains potential for further optimization in how the involved systems communicate. The teams at RaySearch and The Royal Marsden are committed to collaborating to continue refining the integration and enhance system efficiency. The next step in this development is to add RaySearch’s oncology information system RayCare®*, as this is expected to further decrease treatment time.

For centers using RaySearch software, RayStation and RayCare, an online adaptive workflow may be implemented regardless of type of treatment machine, paving the way for a wider implementation of online adaptive radiotherapy.

The first patient was treated radically for endometrial cancer on a Radixact linear accelerator.

Dr Susan Lalondrelle, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, says: “We are extremely proud to be the first cancer center in the world to treat a patient using RaySearch’s advanced online adaptive radiotherapy technology, and we are hugely grateful to The Royal Marsden Cancer Charity for funding this vital equipment. Being able to tailor each treatment session to the patient’s current anatomy, while the patient is on the treatment bed, is a major step forward in delivering more personalized cancer care. This achievement reflects The Royal Marsden’s ongoing commitment to leading innovation in radiotherapy. The Royal Marsden and RaySearch are continuing to work together on future developments which will further enhance cancer care.”

Johan Löf, founder and CEO, RaySearch, says: “Online adaptive has been a key focus for RaySearch for many years and I am happy that The Royal Marsden has treated its first patient using this groundbreaking RayStation technology. RayStation has very advanced tools available for taking online adaptive into clinical practice, and we look forward to collaborating with the team at The Royal Marsden to further improve efficiency in this field, and thereby advance cancer treatment.”

About The Royal Marsden

The Royal Marsden was founded in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education. Today, together with its academic partner, The Institute of Cancer Research (ICR), it is the largest and most comprehensive cancer center in Europe seeing and treating over 59,000 NHS and private patients every year. It is a center of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies.

The Royal Marsden, with the ICR, is the only National Institute for Health Research and Biomedical Research Centre for Cancer. This supports pioneering research work carried out over a number of different cancer themes. The Royal Marsden Cancer Charity raises money solely to support The Royal Marsden, a world-leading cancer center. It ensures Royal Marsden nurses, doctors and research teams can provide the very best care and develop life-saving treatments, which are used across the UK and around the world. From funding state-of-the-art equipment and ground-breaking research, to creating the very best patient environments, The Royal Marsden Cancer Charity will never stop looking for ways to improve the lives of people affected by cancer. royalmarsden.nhs.uk.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.

RaySearch’s software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

About RayStation

RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.

About RayCare

The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.

* Subject to regulatory clearance in some markets.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/the-royal-marsden-first-center-in-the-world-to-treat-a-patient-using-the-new-adaptive-replanning-mod,c4144507

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/the-royal-marsden-first-center-in-the-world-to-treat-a-patient-using-the-new-adaptive-replanning-module-in-raystation-for-online-adaptive-radiotherapy-treatment-302445055.html

SOURCE RaySearch Laboratories